Blue Jet Healthcare Share Price
Small Cap | Pharmaceuticals and health care | NSE: BLUEJET | BSE: 544009
₹711.15 
25.75 (3.76 %)
Last Updated: 30 Apr 2025 03:56 PM
BEARISH
Overview
Open (₹) 698.00
High (₹) 730.10
Low (₹) 682.50
Prev. Close (₹) 685.40
Volume 6,54,607
VWAP (₹) 748.82
ROCE (%) 52.32
Industry P/E 46.44
TTM P/E 52.60
P/B Ratio 0.21
Market Cap (₹) Cr.12,335.99
Dividend Yield (%)0.14
EPS (₹) 1,396.27
ROE40.73%
Sales Growth (%) -1.30
Profit Growth (%)2.33
Day Range
730.10730.10
52 Week Range
346.70968.75
Historical Returns
Returns (6M)
50.48 %
Returns (1Y)
87.05 %
Returns (3Y)
72.02 %
Returns (5Y)
72.02 %
Returns (6M)
50.48 %
Returns (1Y)
87.05 %
Returns (3Y)
72.02 %
Returns (5Y)
72.02 %
SWOT Analysis
- Company with Low Debt
- Growth in Net Profit Margin (QoQ)
- Growth in Annual Net Profit with increasing Profit Margin (YoY)
- Strong long-term momentum: Price above long-term moving averages (EMA_200)
Technicals
Technical Rating
BEARISHRSI 38.86
MFI 49.05
ATR 52.97
Commodity Channel Index -44.46
ROC125 52.41
ROC21 -9.56
Williams %R -50.84
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 781.46 | 800.73 | 830.46 | 751.73 | 732.46 | 702.73 | 683.46 |
| Week Ago | 669.24 | 712.42 | 734.49 | 647.17 | 603.99 | 581.92 | 538.74 |
| Month Ago | 896.14 | 907.42 | 929.99 | 873.57 | 862.29 | 839.72 | 828.44 |
EMA & SMA
711.15
Current Price
Bullish Moving Averages
7
Bearish Moving Averages
13
5 Day 682.76
9 Day 721.46
10 Day 733.88
12 Day 772.70
14 Day 773.75
20 Day 817.50
26 Day 815.87
50 Day 797.28
100 Day 676.76
200 Day 578.08
Deals & Announcements
Bulk and Block Deals
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| VALUEQUEST INVESTMENT ADVISORS PRIVATE LIMITED | bulk | Buy | 1st Nov, 2023 | ₹388.00 | 11,37,541 | NSE |
| NORGES BANK ON ACCOUNT OF THE GOVERNMENT PENSION FUND GLOBAL | bulk | Buy | 1st Nov, 2023 | ₹380.00 | 21,00,000 | NSE |
Insider Trading
Corporate Actions
| Announcement Date | Subject | Ex - Date | Record Date |
|---|---|---|---|
| 27th May, 2024 | Rs.1.0000 per share(50%)Final Dividend | 18th Sept, 2024 | 18th Sept, 2024 |
Announcements
| Date | Source | Detail |
|---|---|---|
| 30th Apr, 2025 | NSE India | Akshay Bansarilal Arora has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. |
| 17th Apr, 2025 | BSE India | <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Blue Jet Healthcare Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L99999MH1968PLC014154</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=''float:left;''> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No</div> <br/><br/><br/> <div style=''float:left;''> Name of the Company Secretary: SWETA PODDAR <br/> Designation: COMPANY SECRETARY AND COMPLIANCE OFFICER <br/> EmailId: companysecretary@bluejethealthcare.com</div> <div ''style=float:left;margin-left:50px;''> Name of the Chief Financial Officer: GANESH K <br/> Designation: CHIEF FINANCIAL OFFICER <br/> EmailId: ganesh.k@bluejethealthcare.com</div> </div> <div> <br/> Date: 17/04/2025<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div> |
| 3rd Apr, 2025 | NSE India | Blue Jet Healthcare Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 |
| 3rd Apr, 2025 | BSE India | Certificate under Reg 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2025 |
| 1st Apr, 2025 | BSE India | Intimation relating to an appeal filed by the Company before Joint Commissioner (Appeals)/ Commissioner of Income-tax (Appeals), Mumbai |
| 1st Apr, 2025 | NSE India | Blue Jet Healthcare Limited has informed the Exchange regarding ''an appeal filed by the Company before the Joint Commissioner (Appeals) /Commissioner of Income-tax (Appeals) Mumbai on March 31, 2025''. |
| 31st Mar, 2025 | NSE India | Blue Jet Healthcare Limited has informed the Exchange regarding ''Assessment orders and demand notices from the Income Tax Department''. |
| 27th Mar, 2025 | NSE India | BLUE JET HEALTHCARE LIMITED has informed the Exchange about Closure of Trading Window |
| 27th Mar, 2025 | NSE India | Blue Jet Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
| 18th Mar, 2025 | NSE India | Blue Jet Healthcare Limited has informed the Exchange about Schedule of meet |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Quarterly Results | -- | 23rd Jan, 2025 | 29th Jan, 2025 |
| Quarterly Results | -- | 24th Oct, 2024 | 29th Oct, 2024 |
| Quarterly Results | -- | 1st Aug, 2024 | 6th Aug, 2024 |
| Audited Results & Dividend | -- | 21st May, 2024 | 25th May, 2024 |
| Quarterly Results | -- | 30th Jan, 2024 | 6th Feb, 2024 |
| Quarterly Results | -- | 7th Nov, 2023 | 10th Nov, 2023 |
Share Holding Pattern
| Owner Name | Mar, 2025 | Dec, 2024 | Dec, 2023 | ||
|---|---|---|---|---|---|
| Promoter Group | 86% | 86% | 86% | 0% | 0% |
| Foreign Institutions + | 2.28% | 1.1% | 2.93% | 0% | 0% |
| Domestic Institutions + | 1.33% | 2.02% | 3.7% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% |
| Public | 10.39% | 10.88% | 7.37% | 0% | 0% |
| Others | 0% | 0% | 0% | 0% | 0% |
About Blue Jet Healthcare
Blue Jet Healthcare is a Public Limited Listed company incorporated on 07/12/1968 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L99999MH1968PLC014154 and registration number is 014154. Currently Company is involved in the business activities of Manufacture of other pharmaceutical and botanical products like hina powder etc.. Company’s Total Operating Revenue is Rs. 711.60 Cr. and Equity Capital is Rs. 34.69 Cr. for the Year ended 31/03/2024.
Parent Organisation
Not Applicable
Founded
1968
Managing Director
Mr. Shiven Akshay Arora
NSE Symbol
BLUEJET
Blue Jet Healthcare Management
| Name | Designation |
|---|---|
| Mr. Akshay Bansarilal Arora | Executive Chairman |
| Mr. Shiven Akshay Arora | Managing Director |
| Mr. Naresh Suryakant Shah | Executive Director |
| Ms. Divya Sameer Momaya | Independent Director |
| Mr. Girish Paman Vanvari | Independent Director |
| Ms. Preeti Gautam Mehta | Independent Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| Sun Pharmaceutical Industries | ₹4,39,630.15 | ₹1,832.30  ₹1,805.50(1.48%) | ₹1,376.750 - ₹1,960.200 |
| Divi's Laboratories | ₹1,61,590.72 | ₹6,087.00  ₹6,108.00(-0.34%) | ₹3,725.550 - ₹6,448.750 |
| Cipla | ₹1,25,192.34 | ₹1,550.10 ₹1,541.50(0.56%) | ₹1,310.050 - ₹1,702.000 |
| Torrent Pharmaceuticals | ₹1,12,431.58 | ₹3,322.00 ₹3,322.70(-0.02%) | ₹2,513.050 - ₹3,589.950 |
| Mankind Pharma | ₹1,01,712.98 | ₹2,465.30 ₹2,556.90(-3.58%) | ₹1,910.100 - ₹3,050.000 |
FAQs on Blue Jet Healthcare
What is the share price of Blue Jet Healthcare?
The share price of Blue Jet Healthcare on 30th Apr, 2025 is ₹ 711.15.
What is 52W high and 52W low share price of Blue Jet Healthcare?
The highest and lowest 52W share prices of Blue Jet Healthcare are ₹ 968.750 and ₹ 346.700
What is the market cap of Blue Jet Healthcare?
The market capitalization of Blue Jet Healthcare as of 30th Apr, 2025 is ₹ 12,335.99 Crores
What is the P/E ratio of Blue Jet Healthcare?
The current P/E ratio of Blue Jet Healthcare as of 30th Apr, 2025 is 46.44
What is the PB ratio of Blue Jet Healthcare?
The PB ratio of Blue Jet Healthcare as of 30th Apr, 2025 is 0.21
Top Gainers
₹78.00
₹65.00 (0.20%)
₹121.03
₹100.86 (0.20%)
₹13.15
₹11.00 (0.20%)
₹1.88
₹1.57 (0.20%)
Top Losers
₹107.95
₹123.00 (-0.12%)
₹0.50
₹0.56 (-0.11%)
₹24.55
₹28.11 (-0.13%)
₹3.34
₹3.80 (-0.12%)
Market Indices
Sensex
₹80,242.24
₹80,288.38 (0.00%)